JAGSONPAL PHARMACEUTICALS
Back to Income Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹209 Cr | ₹237 Cr | ₹218 Cr | ₹188 Cr | ₹159 Cr |
What is the latest Revenue of JAGSONPAL PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹209 Cr |
Mar2023 | ₹237 Cr |
Mar2022 | ₹218 Cr |
Mar2021 | ₹188 Cr |
Mar2020 | ₹159 Cr |
How is Revenue of JAGSONPAL PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹209 Cr | -11.83 | |
Mar2023 | ₹237 Cr | 8.79 | |
Mar2022 | ₹218 Cr | 15.77 | |
Mar2021 | ₹188 Cr | 18.53 | |
Mar2020 | ₹159 Cr | - |
Compare Revenue of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,697.1 Cr | 0.7% | 19.3% | 71.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,267.0 Cr | 0.7% | 2.8% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹178,672.0 Cr | -0.8% | 3.7% | 48.6% | Stock Analytics | |
CIPLA | ₹119,713.0 Cr | -0.2% | -0.1% | -1.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,195.0 Cr | 3.4% | 11.2% | 17.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,999.0 Cr | 0.6% | -5.2% | -4.9% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 0.7% |
19.3% |
71.7% |
SENSEX | -0.9% |
0.4% |
1.4% |
You may also like the below Video Courses